|Study Name||Study Title||Status||Recruit.||Contact|
EXPERT, EXPosurE Registry RiociguaT in patients with pulmona...
A Prospective Observational Registry to describe the disease course and outcomes of Idiopathic Pulmonary Fibrosis patients in a real-world clinic...
A multicenter, randomized, 52-week, double-blind, parallelgroup,
A Prospective Observational Registry to describe the disease course and outcomes of Idiopathic Pulmonary Fibrosis pa...
A 52-week treatment, multi-center, randomized, double blind, double dummy, parallel-group, active controlled study t...
12-week multi-center, randomized, double-blind, parallel-group study to assess the efficacy, safety and tolerability...
A 26-week treatment, multi-center, randomized, double-blind, double dummy, parallel-group study to assess the effica...
This page provides the list of clinical studies currently registered in the LuxCLIN platform in the different therapeutic areas. By clicking on each study title, more information is displayed concerning the study objective and the participation conditions.